Ceramide Synthases CERS5 and CERS6 Regulate Pathways of Programmed Cell Death

神经酰胺合成酶 CERS5 和 CERS6 调节程序性细胞死亡途径

基本信息

  • 批准号:
    7660335
  • 负责人:
  • 金额:
    $ 3.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-15 至 2012-07-14
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Humans, like all organisms, are subject to environmental stresses. To deal with these stresses, such as damage to the DMA or oxidation of proteins and lipids, our cells possess numerous protective mechanisms (e.g. DMA repair or anti-oxidant systems). However, when stresses become too great, our cells are programmed to kill themselves-a process called programmed cell death or apoptosis. Programmed cell death plays important roles in human health and disease; excessive programmed cell death leads to the significant morbidity and mortality associated with ischemic heart disease and stroke, whereas defective cell death leads to the second greatest cause of mortality in the United States, cancer. Sphingolipids are important regulators of cell growth and death. Ceramide, a bioactive sphingolipid, is an essential mediator of programmed cell death. Ceramide is produced by ceramide synthases (CerSes) during cell death, and there is an accumulating body of evidence that these enzymes play specific roles in regulating ceramide generation and cell death. However, the mechanisms of CerS- and ceramide-mediated cell death are ill-defined and warrant further study. By understanding the details of these pathways we will be able to identify targets of therapeutic interest. The goal of this project is to determine the role of CerSS and CerS6 in mediating programmed cell death. This project will utilize the MCF-7 breast adenocarcinoma cell line to investigate the contribution of CerSS and CerS6 to cell death induced by the genotoxic stress ultraviolet light (UVC). In preliminary investigations, the pro-death protein Bax has emerged as a downstream target of CerSS and CerS6- mediated ceramide production in UVC-induced death. The aims of this study are 1) determine how CerSS and CerS6 regulate cell death; 2) determine how CerSS and CerS6 are regulated during cell death; and 3) determine whether CerSS or CerS6-mediated ceramide production is sufficient to activate cell death pathways (e.g Bax). The primary methodology of these studies will be to overexpress or knockdown CerSS and CerS6 and examine subsequent effects on Bax activation and other parameters of cell death. This project represents an incremental step in achieving our long-term goal of determining the mechanisms of ceramide-mediated programmed cell death. Human cells respond to excessive stress by making a decision to kill themselves. This project seeks to determine how the lipid ceramide and the enzymes that make ceramide regulate this decision.
描述(由申请人提供):人类,像所有生物一样,会受到环境压力的影响。为了应对这些压力,例如对DMA的损伤或蛋白质和脂质的氧化,我们的细胞拥有许多保护机制(例如DMA修复或抗氧化系统)。然而,当压力过大时,我们的细胞就会自动杀死自己——这一过程被称为程序性细胞死亡或细胞凋亡。程序性细胞死亡在人类健康和疾病中起着重要作用;过度的程序性细胞死亡导致与缺血性心脏病和中风相关的显著发病率和死亡率,而缺陷性细胞死亡导致美国第二大死亡原因——癌症。鞘脂是细胞生长和死亡的重要调节因子。神经酰胺是一种生物活性鞘脂,是程序性细胞死亡的重要介质。神经酰胺是由神经酰胺合成酶(CerSes)在细胞死亡过程中产生的,越来越多的证据表明这些酶在调节神经酰胺的产生和细胞死亡中起着特定的作用。然而,cer和神经酰胺介导的细胞死亡机制尚不明确,值得进一步研究。通过了解这些途径的细节,我们将能够确定治疗兴趣的靶点。该项目的目标是确定CerSS和CerS6在介导程序性细胞死亡中的作用。本项目将利用MCF-7乳腺腺癌细胞系研究CerSS和CerS6在基因毒性应激紫外线(UVC)诱导的细胞死亡中的作用。在初步研究中,促死亡蛋白Bax已成为uvc诱导死亡中CerSS和CerS6介导的神经酰胺生成的下游靶点。本研究的目的是:1)确定CerSS和CerS6如何调节细胞死亡;2)确定细胞死亡过程中CerSS和CerS6是如何调控的;3)确定CerSS或cers6介导的神经酰胺产生是否足以激活细胞死亡途径(例如Bax)。这些研究的主要方法将是过表达或敲低CerSS和CerS6,并检查对Bax激活和其他细胞死亡参数的后续影响。这个项目代表了我们在确定神经酰胺介导的程序性细胞死亡机制的长期目标上迈出的一步。人类细胞对过度压力的反应是决定自杀。该项目旨在确定脂质神经酰胺和制造神经酰胺的酶如何调节这一决定。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas D Mullen其他文献

Thomas D Mullen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas D Mullen', 18)}}的其他基金

Ceramide Synthases CERS5 and CERS6 Regulate Pathways of Programmed Cell Death
神经酰胺合成酶 CERS5 和 CERS6 调节程序性细胞死亡途径
  • 批准号:
    8112516
  • 财政年份:
    2008
  • 资助金额:
    $ 3.64万
  • 项目类别:
Ceramide Synthases CERS5 and CERS6 Regulate Pathways of Programmed Cell Death
神经酰胺合成酶 CERS5 和 CERS6 调节程序性细胞死亡途径
  • 批准号:
    7544413
  • 财政年份:
    2008
  • 资助金额:
    $ 3.64万
  • 项目类别:

相似海外基金

Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
  • 批准号:
    24K18002
  • 财政年份:
    2024
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
  • 批准号:
    2222215
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
  • 批准号:
    23K09272
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
  • 批准号:
    10652764
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
  • 批准号:
    10730652
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
  • 批准号:
    22K11609
  • 财政年份:
    2022
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
  • 批准号:
    22K16720
  • 财政年份:
    2022
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
  • 批准号:
    RGPIN-2018-04107
  • 财政年份:
    2022
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
  • 批准号:
    RGPIN-2019-05674
  • 财政年份:
    2022
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
  • 批准号:
    22K12824
  • 财政年份:
    2022
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了